Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
07/01/2010 | US20100166702 Alkylated interleukin-18 and related compositions, kits, and methods of making and using same |
07/01/2010 | US20100166654 Single-Drug Multi-Ligand Conjugates for Targeted Drug Delivery |
07/01/2010 | CA2747996A1 Compounds and methods for enhancing erythropoiesis |
07/01/2010 | CA2747992A1 Dosage regimen of an s1p receptor agonist |
07/01/2010 | CA2747951A1 Compounds and methods for the treatment of autoimmune and inflammatory disease |
07/01/2010 | CA2747802A1 Dosage regimen for a s1p receptor agonist |
07/01/2010 | CA2747795A1 Isoquinoline derivative |
07/01/2010 | CA2745901A1 Compositions and methods for inhibition of the jak pathway |
06/30/2010 | EP2202315A1 Modified vaccinia ankara virus variant |
06/30/2010 | EP2202240A1 Compound |
06/30/2010 | EP2202235A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof |
06/30/2010 | EP2202229A1 Novel preparation for external use |
06/30/2010 | EP2201959A2 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
06/30/2010 | EP2201957A1 Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
06/30/2010 | EP2201007A1 Cannabinoid receptor ligands |
06/30/2010 | EP2201006A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
06/30/2010 | EP2200613A2 Phenazine derivatives and uses thereof |
06/30/2010 | EP2200595A2 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
06/30/2010 | EP1891008B1 Oxindoles as kinase inhibitors |
06/30/2010 | EP1721985B1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
06/30/2010 | EP1689433B1 Compositions and methods for activating innate and allergic immunity |
06/30/2010 | EP1578799B1 Antibodies directed to tumor necrosis factor and uses thereof |
06/30/2010 | EP1545548B1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
06/30/2010 | EP1399183B1 Chimeric alphavirus replicon particles |
06/30/2010 | EP1379625B1 Cd4+cd25+ regulatory t cells from human blood |
06/30/2010 | EP1332366B1 Methods for the Assessment of Cellular Proliferative Disorders |
06/30/2010 | EP1330436B1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists |
06/30/2010 | EP1036164B1 Chemokine alpha-5 |
06/30/2010 | CN101765424A Use of antivirals in the treatment of medical disorders |
06/30/2010 | CN101760390A Production method of wine for keeping in good health |
06/30/2010 | CN101759760A Preparation of fluorine-containing steroid hormone |
06/30/2010 | CN101759727A Nano-scale pine bark extract and preparation method thereof |
06/30/2010 | CN101759683A Preparation method of hydrindene amide compound, medical composition comprising hydrindene amide compound and application thereof as protein kinase inhibitor |
06/30/2010 | CN101759626A Novel compounds from antrodia camphorata |
06/30/2010 | CN101757638A Nasal medicine composition enclosing budesonide by cyclodextrin |
06/30/2010 | CN101757637A Nasal pharmaceutical composition adopting cyclodextrin to include triamcinolone acetonide or 21-acetic ester thereof |
06/30/2010 | CN101757636A Nasal pharmaceutical composition adopting cyclodextrin to include ciclesonide |
06/30/2010 | CN101757635A Nasal pharmaceutical composition adopting cyclodextrin to include methylprednisolone aceponate |
06/30/2010 | CN101757634A Nasal medicine composition enclosing fluticasone propionate by cyclodextrin |
06/30/2010 | CN101757625A Nasal pharmaceutical composition of cyclodextrin inclusion cortin and H1 receptor antagonist |
06/30/2010 | CN101757609A Method for controlling residue of organic solvent in thymic peptide alpha1 microballoon |
06/30/2010 | CN101757604A Immune polysaccharide intensifier and preparation method and application thereof |
06/30/2010 | CN101757588A Traditional Chinese medicine preparation for treating urticaria |
06/30/2010 | CN101757582A Traditional Chinese medicine preparation for treating chronic urticaria |
06/30/2010 | CN101757516A Prescription of traditional Chinese medicine for treating infantile allergic asthma |
06/30/2010 | CN101757462A Traditional Chinese medicine formula for treating SLE |
06/30/2010 | CN101757453A American ginseng-glossy ganoderma-dendrobe preparation and preparation method thereof |
06/30/2010 | CN101757451A Natural galenical preparation for promoting nutrition rehabilitation of mucous membrane of animal and preparing method thereof |
06/30/2010 | CN101757434A Health-care medicated wine for nourishing yin and invigorating the kidney as well as blackening the hair and beautifying and preparation method thereof |
06/30/2010 | CN101757431A Ejiao Jinshui paste |
06/30/2010 | CN101757424A Traditional Chinese medicine preparation for treating heart diseases |
06/30/2010 | CN101757408A Medicament for treating lupus erythematosus and preparation method thereof |
06/30/2010 | CN101757365A Making method of wine for nourishing viscera and strengthening spirit |
06/30/2010 | CN101757307A Traditional Chinese medicine preparation for treating acute urticaria |
06/30/2010 | CN101757249A Ejiao Eling paste |
06/30/2010 | CN101757244A Capsule for treating erythra |
06/30/2010 | CN101757229A Traditional Chinese medicine composite for treating horse eczema |
06/30/2010 | CN101757226A Ejiao developmental paste |
06/30/2010 | CN101757158A American ginseng rose buccal tablet |
06/30/2010 | CN101757125A Traditional Chinese medicine composite for treating horse urticaria |
06/30/2010 | CN101757115A American ginseng mulberry leaf buccal tablet |
06/30/2010 | CN101757112A Fig-American ginseng buccal tablet |
06/30/2010 | CN101757088A Health-care capsule |
06/30/2010 | CN101757086A Traditional Chinese medicine health-care capsule |
06/30/2010 | CN101757080A Honeysuckle-Sanchi buccal tablets |
06/30/2010 | CN101757066A American ginseng tabellae iodi gurgitis |
06/30/2010 | CN101757064A American ginseng pseudo-ginseng buccal tablet |
06/30/2010 | CN101757057A Whiteflower leadword root chewable tablet |
06/30/2010 | CN101757049A Ginkgo leaf extractive and method for extracting total ginkgoic acid in preparation thereof |
06/30/2010 | CN101757046A Cold and heat resisting oral solution prepared by taking pine and cypress leaves as raw materials |
06/30/2010 | CN101757045A Preparation method of pachyman |
06/30/2010 | CN101757041A Bacillus calmette-guerin polysaccharide and nucleic acid preparation for treating respiratory diseases for livestock |
06/30/2010 | CN101757038A Honey pollen capsule |
06/30/2010 | CN101757029A Method for extracting transfer factors from cattle spleen |
06/30/2010 | CN101756998A Nasal pharmaceutical composition adopting cyclodextrin to include momestasone furoate |
06/30/2010 | CN101756988A Compound matrine and diversine nano-emulsion preparation and preparation method thereof |
06/30/2010 | CN101756979A Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof |
06/30/2010 | CN101317852B Powder injection of compound glycyrrhizic acid glycosides and preparation method thereof |
06/30/2010 | CN101210044B Polypeptide and application thereof |
06/29/2010 | US7745638 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide |
06/29/2010 | US7745572 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
06/29/2010 | US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
06/29/2010 | US7745454 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
06/29/2010 | US7745450 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
06/29/2010 | US7745424 Osteoporosis, bone cancer; antiarthritic agents;paget's disease; antiinflammatory agents |
06/29/2010 | US7745420 stability, high effectiveness and low toxicity; for treating pulmonary/respiratory diseases such as cystic fibrosis, asthma, chronic bronchitis, chronic obstructive lung disease, eosinophilic bronchitis |
06/29/2010 | US7745212 Melanoma antigens and their use in diagnostic and therapeutic methods |
06/29/2010 | US7745139 for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension |
06/29/2010 | US7744909 Dispersions for the formulation of slightly or poorly soluble agents |
06/29/2010 | US7744896 therapeutic vaccine anti-HIV, anti-AIDS and against tumors and syndromes associated with HIV infection |
06/29/2010 | US7744888 Controlling immunology response; autoimmune disease, antiallergens |
06/29/2010 | US7744886 Methods for interfering with rank signaling |
06/29/2010 | US7744863 inhibiting Th1 immune response of an anti-CD3 monoclonal antibody and IL-5; type I diabetes, multiple sclerosis, rheumatoid arthritis, psoriasis, glomerulonephritis, myasthenia gravis, chronic inflammatory demyelinating neuropathy and inflammatory bowel disease; autoimmune disease |
06/29/2010 | CA2424596C Oral self-emulsifying formulations of pyranone protease inhibitors |
06/29/2010 | CA2409090C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
06/29/2010 | CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug |
06/29/2010 | CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment |
06/29/2010 | CA2337969C Compound and method for the prevention and/or the treatment of allergy |
06/29/2010 | CA2312188C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |